Acumen Pharmaceuticals, Inc. (ABOS)
Market Closed
28 Mar, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
1. 19
-0.04
-3.25%
$
142.39M Market Cap
- P/E Ratio
0% Div Yield
118,800 Volume
- Eps
$ 1.23
Previous Close Day Range
1.15 1.25
Year Range
1.1 4.28
Earnings results expected in 44 days
Want to track ABOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| ABOS Acumen Pharmaceuticals, Inc. 12 May 2025 (44 Days) | | - Cons. EPS | - EPS |
| ABOS Acumen Pharmaceuticals, Inc. 24 Mar 2025 | | - Cons. EPS | - EPS |
| ABOS Acumen Pharmaceuticals, Inc. 13 Nov 2024 | | - Cons. EPS | - EPS |
| ABOS Acumen Pharmaceuticals, Inc. 13 Aug 2024 | | - Cons. EPS | - EPS |
| ABOS Acumen Pharmaceuticals, Inc. 8 Aug 2024 | | - Cons. EPS | - EPS |
| ABOS Acumen Pharmaceuticals, Inc. 4 Jun 2024 | | - Cons. EPS | - EPS |
| ABOS Acumen Pharmaceuticals, Inc. 14 May 2024 | | - Cons. EPS | - EPS |
| ABOS Acumen Pharmaceuticals, Inc. 26 Mar 2024 | | - Cons. EPS | - EPS |
| ABOS Acumen Pharmaceuticals, Inc. 25 Mar 2024 | | - Cons. EPS | - EPS |
| ABOS Acumen Pharmaceuticals, Inc. 13 Nov 2023 | | - Cons. EPS | - EPS |
2025 © Marketlog. All Rights Reserved.
